International Scholarly Research Notices

International Scholarly Research Notices / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 839560 | 10 pages | https://doi.org/10.1155/2014/839560

Factor VIII-Related Antigen Detects Phenotypic Change of Sinusoidal to Vascular Endothelium in Hepatic Fibrosis of Elderly Cadavers

Academic Editor: Zvi Ackerman
Received17 Mar 2014
Revised29 May 2014
Accepted06 Jul 2014
Published22 Sep 2014

Abstract

In advanced stages of hepatic fibrosis, the liver sinusoidal endothelium transforms to vascular endothelium with accompanying expression of factor VIII-related antigen (FVIIIRAg), a phenotypic marker of vascular endothelial cells. Liver fibrosis has been shown to be associated with aging and was found to be prevalent in elderly cadavers. Using immunohistochemistry, we studied FVIIIRAg expression in the livers of elderly cadavers with progressive stages of fibrosis. The vascular endothelium of portal tracts and central veins was stained for FVIIIRAg, providing an internal positive control. The incidence of FVIIIRAg expression was low in the sinusoids of livers that showed minimal fibrosis or perisinusoidal fibrosis but was increased in livers with advanced fibrosis (i.e., septa formation, bridging fibrosis, and cirrhosis). FVIIIRAg positive sinusoidal endothelial cells were distributed in loose aggregates in the periportal, periseptal, and midlobular parenchyma and were found less frequently in the centrilobular area. FVIIIRAg immune deposits appeared patchy and discontinuous along the sinusoidal lining, likely representing focalized transformation of sinusoidal to vascular endothelium. There was a discrete localization of FVIIIRAg immunoreactivity in the foci of severe parenchymal fibrosis. Conclusion. FVIIIRAg is a reliable marker for detecting the transformation of sinusoidal to vascular endothelium in advanced liver fibrosis in elderly cadavers.

1. Introduction

The liver parenchyma is extensively supplied by sinusoids that are lined by endothelial cells, which contain fenestrae but lack a continuous basal lamina when viewed by electron microscopy [1, 2]. Liver sinusoids are considered capillaries of the liver and are classified as discontinuous capillaries [3, 4]. The structure of the sinusoids is uniquely adapted to the many functions of the liver, ultrafiltration, endocytosis, and immunological roles [5], and changes in these functions associated with the aging liver were reviewed by Le Couteur et al. [6]. In chronic liver diseases with particularly severe fibrotic changes, the fenestrated endothelial cells undergo striking morphological changes to nonfenestrated endothelial cells accompanied by the appearance of a basal lamina, forming vascular type endothelium or continuous capillaries as seen in the systemic vasculature. This transformation represents a significant pathology known as the capillarization of hepatic sinusoids [7], which can be observed in alcoholic liver disease, primary biliary cirrhosis, and autoimmune hepatitis [810], as well as experimental hepatic cirrhosis in rats [4, 11, 12]. The development of capillarized sinusoids will cause a perturbation in hepatic microcirculation and compromise the exchange of materials across the endothelium and the space of Disse between the sinusoidal blood and parenchymal cells [4].

Factor VIII-related antigen (FVIIIRAg), also known as von Willebrand factor, is a multimeric glycoprotein that binds and stabilizes the coagulation factor VIII as well as mediating platelet adhesion to injured vessels [13]. In most vascular endothelial cells of the systemic vasculature, FVIIIRAg is stored in membrane bound inclusions called Weibel-Palade bodies [14]. The antigen is expressed by both vascular endothelial cells and platelets and is often used as a phenotypic marker to identify the vascular endothelium [13]. Furthermore, FVIIIRAg is not normally expressed in liver sinusoidal endothelial cells of the healthy human liver; therefore, it can be used as a tool to demonstrate the transformation of sinusoidal endothelium to the vascular-type endothelium associated with chronic liver diseases [9, 10, 1517].

Fibrotic changes are often seen in aged livers [1820]. Hepatic fibrosis is prevalent in the elderly cadavers, even when liver disease is not indicated as the cause of death [21]. However, it is not known whether the transformation of liver sinusoidal endothelial cells to vascular endothelial cells occurs in the liver samples of the aged cadavers. Accordingly,we sought to determine (1) whether FVIIIRAg could serve as a reliable immunohistochemical marker for assessing phenotypic change of liver sinusoidal to vascular endothelium, (2) the incidence of FVIIIRAg expression in the liver with progressive stages of fibrosis, and (3) the anatomic sites of FVIIIRAg expression that mark the location of vascular endothelium formation within the liver lobules.

2. Materials and Methods

2.1. Liver Specimens

Paraffin embedded liver tissue of embalmed elderly cadavers from our previous study provided the source of specimens in the present investigation [21]. These liver samples (; mean age  years) were collected from cadavers at the end of the Anatomy Course at the Icahn School of Medicine at Mount Sinai, when the organs were no longer needed. Liver tissue ( block) was excised from the right lobe of the liver, compatible with the area where needle biopsies were taken from patients for histopathologic diagnosis. Thus, the tissue is a representative sample of the liver, although only one block of tissue was taken per liver. The specimens were deidentified and labeled numerically so that they could not be linked to the particular subjects. Permission to collect cadaveric livers was granted by the Administrative Manager of Laboratories and Facilities, Department of Medical Education, and the protocol was approved by institutional grants and contracts office.

To these samples, we added 12 additional liver specimens from the 2012 Fall Anatomy Course. The embalming fluid contained formaldehyde (2.2%), methanol (24.9%), and phenol (25%). As previously described [21], embalmed cadaveric livers presented variable tissue preservation histologically—good, fair, or poor—evaluated by hematoxylin and eosin staining. Fibrosis was determined using Sirius red stain for collagens. The classification was previously detailed [21]. Based on the combined fibrotic changes and the quality of tissue preservation (good and fair), we selected 52 liver samples (mean age, years) for the present investigation. Of these, 8 showed minimal fibrosis, 9 perisinusoidal/pericellular fibrosis (with no accompanying septal fibrosis), 15 septa formation, 15 bridging fibrosis, sometimes designated as incomplete cirrhosis or precirrhosis, and 5 cirrhosis. The latter 3 stages of fibrosis were considered advanced fibrosis in our study. These livers also had variable degrees of perisinusoidal/pericellular fibrosis in the parenchyma. None of the cadavers were reported to have died from liver disease. The most common causes of death were cardiovascular disease, pulmonary disease, and cancer.

2.2. Antibodies and Antigen-Retrieval Reagent

The primary antibody was rabbit polyclonal FVIIIRAg, purchased from Cell Marque (Rocklin, CA). The secondary antibody was anti-rabbit polymer-horseradish peroxidase (polymer-HRP) from the Dako EnVision + System-HRP/DAB (Dako, Carpinteria, CA, USA). Trilogy was obtained from Cell Marque. It is an EDTA-based solution that combines the steps of deparaffinization, rehydration, and antigen unmasking in immunohistochemical staining of paraffin embedded tissue sections—vide infra.

2.3. Immunohistochemistry

Paraffin liver sections were cut at a thickness of 5 μm and placed on Superfrost Plus glass slides (Fisher Scientific, Pittsburgh, PA, USA). Sections were simultaneously deparaffinized, rehydrated, and antigen unmasked using Trilogy according to the manufacturer’s instruction. The slides were heated in Trilogy in a staining dish to subboiling temperature for 30 min in a kitchen-type steamer, followed by rinsing in another hot dish of Trilogy for an additional 30 min. After cooling, the slides were washed three times in distilled water and then phosphate-buffered saline (PBS). Liver sections were sequentially incubated with a peroxide block for 10 min, a nonspecific protein block for 10 min, and FVIIIRAg antibody (1 : 100 in 1% bovine serum albumin in PBS) for 60 min at room temperature or 20 hr at 4°C. No difference was detected in the staining intensity between these two durations of treatments with the antibody. The immunoreaction was detected using the anti-rabbit polymer-HRP for 30 min at room temperature. Color reaction was revealed by treatment with the chromogen 3.3′-diaminobenzidine tetrahydrochloride (DAB) to yield a brown reaction product. Sections were counterstained with Harris hematoxylin for nuclei. Some selected sections were poststained with Sirius red for 1 hr at room temperature for visualizing fibrous collagenous tissue as previously described [22]. Sections that were not treated with Trilogy did not show any detectable immunostaining for FVIIIRAg.

For each individual liver, one section was used for assessment of liver fibrosis by Sirius stain for collagens and two nonoverlapped sections were used for evaluation of FVIIIRAg immunostaining. These liver sections—approximately 1 1 cm2—were about 10 times larger than needle biopsy sections; the latter are considered the gold standard in hepatic histopathologic evaluation. Because of their size, the sections offered many histologically well-defined classic liver lobules—generally about 15–20—for objective assessment of FVIIIRAg immunostaining and its intralobular distribution within the lobules.

2.4. Scoring of Incidence of FVIIIRAg Expression

The scoring was performed based on the presence/absence of FVIIIRAg staining in the liver lobular parenchyma. For each liver, two nonoverlapped sections were examined. These liver sections provided well-marked liver lobules for the analysis—vide supra. A liver was scored positive for FVIIIRAg expression when the staining was detected—focal, scattered, or diffuse—in any part of the lobular parenchyma. A negative case was scored when no staining was visible. The incidence of FVIIIRAg expression was expressed as the number positive cases per number of livers examined. The difference in the incidence between groups was analyzed by chi-square test, and was considered to be significant.

3. Results

3.1. Vascular Endothelium of Portal Tracts and Central Veins

To test whether FVIIIRAg can be used as a phenotypic marker for the vascular endothelium in the cadaveric liver, we examined the antigen immunoreactivity in the endothelium of portal tracts and central veins (also called terminal hepatic venules). Figure 1 shows that the endothelium of the terminal portal venules and hepatic arterioles was stained uniformly with the FVIIIRAg antibody. Portal biliary epithelial cells, basement membranes, arteriolar smooth muscle, stromal cells, and matrix were all negative for FVIIIRAg. The staining reactions were similar in portal tracts, whether they showed fibrosis or not. In central veins showing fibrosis, the endothelium of the fibrotic veins was stained uniformly for FVIIIRAg; however, the matrix of the thickened wall of the veins was negative for FVIIIRAg (Figure 2(a)). In nonfibrotic veins, the endothelial cells were also positive for FVIIIRAg (Figure 3(b)). These findings demonstrate that FVIIIRAg expression represents a reliable phenotypic marker of the vascular endothelium of the systemic vasculature. In particular, the immunoreactivity of portal vessels and central veins for FVIIIRAg provides an internal positive control for determining the development of vascular endothelial phenotype in sinusoids of the liver parenchyma. Thus, when the staining reaction for FVIIIRAg in the sinusoidal endothelium was identical to that in the portal vessels and central veins, the reaction was classified as positive.

3.2. Sinusoidal Endothelial Cells

Endothelial cells lined the lumen of liver sinusoids. As illustrated in Figure 3(a), the cell typically contained an oval nucleus with scant perinuclear cytoplasm that slightly bulged into the lumen. The cytoplasmic processes extending from the cell body were thin and oriented along the sinusoid, forming the sinusoidal wall. In the endothelial cells stained positively for FVIIIRAg, the immune deposits were visible as fine granules—less than 1 μm in diameter—in the perinuclear cytoplasm and cell processes. In areas of the parenchyma where focal perisinusoidal fibrosis developed, FVIIIRAg immunoreactive endothelial cells could be seen overlying bundles of collagen fibers in the space of Disse (Figures 3(b) and 3(c)), presumably representing a morphological link between the histogenesis of vascular endothelium and fibrogenesis of the space of Disse. The histological features of FVIIIRAg staining of sinusoidal endothelial cells are further illustrated in Figures 4(a) and 4(b), photographed from a cirrhotic liver.

In many specimens, FVIIIRAg stained platelets—measured 2–4 μm in diameter—were seen in the sinusoidal lumen (Figures 5(a) and 5(b)). The immunostaining of platelets for FVIIIRAg validates the immunospecificity of the FVIIIRAg antibody.

3.3. Incidence of FVIIIRAg Expression

We then determined the incidence of FVIIIRAg expression—positive staining—in the liver lobules of the aged cadavers with progressive stages of fibrosis. Expression of FVIIIRAg in sinusoidal endothelium was found in one of the nine livers showing minimal fibrotic change and two of the eight livers with perisinusoidal/pericellular fibrosis. The incidence of livers showing positive FVIIIRAg staining was increased in the livers with advanced fibrosis—septa formation (8/15 livers), bridging fibrosis with linking septa (11/15 livers), and cirrhosis (3/5 livers). As summarized in Table 1, the chi-square test indicated that the incidence of septa formation was significantly higher than minimal fibrosis (); there was a suggestion of a higher incidence than perisinusoidal/pericellular fibrosis, though not statistically significant (). The incidence of bridging fibrosis was significantly higher than minimal fibrosis () or perisinusoidal/pericellular fibrosis (). Cirrhotic livers showed a trend of increased incidence compared with minimal fibrosis or perisinusoidal/pericellular fibrosis, though not statistically significant ( or , resp.).


Stages of fibrosisIncidence

Minimal fibrosis1/9
Perisinusoidal/pericellular fibrosis2/8
Septa formation8/15a
Bridging fibrosis11/15b
Cirrhosis3/5c

Incidence was expressed as number of positive cases/number of livers.
Statistics were performed by the chi-square test. A value of was considered to be significant.
aSepta formation versus minimal fibrosis, ; septa formation versus perisinusoidal/pericellular fibrosis, .
bBridging fibrosis versus minimal fibrosis, ; bridging fibrosis versus perisinusoidal/pericellular fibrosis, .
cCirrhosis versus minimal fibrosis, ; cirrhosis versus perisinusoidal/pericellular, .

3.4. Anatomical Sites of FVIIIRAg Expression

Next, we examined the anatomical sites of FVIIIRAg immunoreaction within the liver lobules. FVIIIRAg stained sinusoidal endothelial cells were commonly observed in the periportal parenchyma nearby enlarged fibrotic portal tracts (Figure 6(a)). In the areas of the lobules where fibrous septa were found, FVIIIRAg-positive sinusoidal endothelium was seen in the parenchyma alongside the developing and bridging septa (Figures 6(b) and 6(c)). The sinusoidal endothelium showing FVIIIRAg immunoreactivity also developed in the midlobular parenchyma, sometimes in association with perisinusoidal/pericellular fibrosis but infrequently in the centrilobular areas (Figures 7(a) and 7(b)). Histologically, the sinusoidal endothelial cells positive for FVIIIRAg were distributed in loose aggregates and the immune deposits of FVIIIRAg were patchy and discontinuous along the sinusoidal lining. These observations likely represent the focal transformation of sinusoidal endothelium to vascular endothelium. However, FVIIIRAg-positive endothelial cells, either in groups of a few cells or singly, were also found scattered throughout the lobules (Figures 7(c) and 7(d)). Strikingly, when foci of severe parenchymal fibrosis were detectable in the lobules, a discrete localization of FVIIIRAg immunoreactivity was observed in the lesion (Figures 8(a) and 8(b)), which suggests the involvement of sinusoidal transformation in liver fibrogenesis.

3.5. Fibrous Septa

Septa formation and bridging septa are advanced fibrotic changes associated with the stages of septal fibrosis and cirrhosis. The septa are made up of vascularized fibrous tissue containing ductular structures and mesenchymal cells [22, 23]. Figures 9(a) and 9(b) show that the vessels in the septa were stained for FVIIIRAg, indicating a phenotype associated with the systemic vascular endothelium. No other structures in the septa were stained.

3.6. Microscopic Fibrous Scars

Small fibrous scars, measured less than 100 μm across, were frequent in the parenchyma of cadaveric livers with advanced stages of septa formation and bridging fibrosis, particularly in the midlobular area [23]. In the matrix of these scars, microvessels with endothelium stained positively for FVIIIRAg could be seen (Figure 9(c)). These vessels lacked a muscular wall and have capillary-like features, as they may represent capillarized sinusoids.

4. Discussion

In this study, we first documented the localization of FVIIIRAg in the vascular endothelium of portal vessels and central veins, which are the systemic vasculature. The findings are consistent with the notion that FVIIIRAg is a specific phenotypic marker of vascular endothelial cells, thereby validating its expression in the lobular sinusoids as representative of phenotypic transformation to vascular endothelium in the aged cadaveric livers. In support of this contention, we have examined three cases of archival, deidentified adult human livers with little or no fibrotic changes and found that FVIIIRAg staining was uniformly present in the endothelium of portal vessels and central veins but was absent from the sinusoidal endothelium of the lobular parenchyma (unpublished observations). These data are in accord with the observations of others in the human liver with nearly normal histology [9, 10, 1517] and in normal rat and guinea pig livers [24]. Appropriately, the immunoreactivity of vascular endothelial cells in portal tracts and central veins provides an internal positive control for the assessment of FVIIIRAg expression in the sinusoids of liver lobules.

We found that the incidence of FVIIIRAg expression was low in the livers with minimal fibrotic change or perisinusoidal/pericellular fibrosis, while the incidence was significantly higher or showed a trend of increase in the livers with advanced stages of septal fibrosis and cirrhosis. While these findings principally corroborate the studies of others reporting transformation of liver sinusoidal endothelium to FVIIIRAg-positive cells in advanced hepatic fibrotic disease of various causes [9, 10, 1517], our study of aged cadavers with progressive stages of fibrosis also provides important data on the anatomical sites of FVIIIRAg expression as well as the histopathology of sinusoidal transformation to vascular endothelium within the liver lobules that have not previously been described. Our investigation is also unique as it is dealing with fibrosis under aging conditions—an understudied but clinically relevant issue.

It is known that the pathogenesis of vascular endothelium in the liver lobules is accompanied by the formation of a basement membrane beneath the endothelium in the space of Disse. Indeed, we found in our previous study [23] an enhanced production of perisinusoidal basement membrane in the cadaveric livers with advanced fibrotic changes, as evidenced immunohistochemically by the codistribution in the sinusoidal lining of laminin and type IV collagen, which are two major basement membrane proteins. This raises the possibility that, in the fibrotic liver of the aged cadavers, the formation of vascular endothelium and development of perisinusoidal basement membrane in the space of Disse together may transform the sinusoids into continuous capillaries. There appears to be a correspondence between the anatomical sites of sinusoidal transformation and that of perisinusoidal basement membrane formation within the liver lobules. However, confirmation of this requires a demonstration of codistribution of FVIIIRAg along with laminin and collagen IV in the sinusoidal lining. This remains to be studied.

Our study revealed that the incidence of FVIIIRAg expression was low in the aged liver of cadavers with minimal fibrotic change or perisinusoidal/pericellular fibrosis. The findings suggest that, at these early stages of liver fibrosis, vessels within the liver lobules remain largely sinusoidal and, thus, may have little impact on the exchange of materials between the sinusoidal blood and liver parenchyma. However, we also found that, even in the advanced stages of liver fibrosis in which the incidence of positive FVIIIRAg staining is higher, the immunostaining of sinusoidal endothelium is not diffusely panlobular but is characteristically patchy and discontinuous along the sinusoidal lining. Accordingly, this staining pattern reflects that the transformation to vascular endothelium is focal, rather than diffuse, in fashion. Thus, in the parenchyma of these fibrotic livers, while many sinusoidal vessels have become capillarized, others remain sinusoidal. Physiologically, in the areas of the parenchyma where sinusoidal capillarization prevails, periportal, periseptal, midlobular, or foci with extensive fibrosis, the exchange of materials across the endothelium between the sinusoidal blood and liver parenchyma could be compromised. This effect may lead to localized dysfunction of hepatocytes. Conversely, the presence of nontransformed sinusoidal endothelium could provide a local pathway for the bidirectional exchange of metabolites, thereby sustaining local hepatic functions. Nonetheless, the lesions could collectively have resulted in a substantial loss of hepatic function in these elderly individuals and may have aggravated their existing health conditions.

It has been reported that the FVIIIRAg immunostaining was enhanced in liver sinusoids of elderly humans, baboons, and rats with normal histology, whereas it was undetectable in the respective younger counterparts [2527]. Although to date there is no study that looks specifically at the incidence of sinusoidal capillarization in the aging human liver, pseudocapillarization of sinusoids—a near identical histological lesion to sinusoidal capillarization—has been described in the liver of aged people, even in the absence of active perisinusoidal fibrogenesis [6, 25]. This pathological process, detailed previously, has been regarded to be an age-related change. Therefore, it might be presumed that the increase in FVIIIRAg expression and the associated sinusoidal transformation to vascular endothelium observed in the elderly cadavers are also related to aging of the liver but are nonetheless exacerbated by the development of advanced fibrogenesis.

In conclusion, FVIIIRAg is a reliable immunohistochemical marker for vascular endothelium, providing a tool for detecting the transformations of sinusoidal endothelial cells to vascular endothelial cells and of sinusoids to capillaries within the liver lobules of elderly cadavers. The incidence of vascular endothelium formation is low in the early stages of hepatic fibrosis but becomes prevalent in the advanced stages of fibrosis. The replacement of sinusoidal endothelium by the vascular type in the liver parenchyma appears to be focalized, rather than diffuse, in fashion, and thus its impairment of hepatic functions may be localized. By examining the aged cadaveric livers, our study provides significant scientific information that advances our understanding of the pathogenesis of sinusoidal transformation to vascular endothelium in association with hepatic fibrosis in the aging human.

Conflict of Interests

The authors declare that they have no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors wish to acknowledge the support by the Research Fund of the Center for Anatomy and Functional Morphology. The authors also thank Dr. Scott L. Friedman, Division of Liver Diseases at Icahn School of Medicine, for providing them with technical support in this project.

References

  1. E. Wisse, R. B. de Zanger, K. Charels, P. van der Smissen, and R. S. McCuskey, “The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse,” Hepatology, vol. 5, no. 4, pp. 683–692, 1985. View at: Publisher Site | Google Scholar
  2. K. M. Mak and C. S. Lieber, “Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol: a scanning electron microscopic study,” Hepatology, vol. 4, no. 3, pp. 386–391, 1984. View at: Publisher Site | Google Scholar
  3. N. Simionescu and M. Simionescu, “The cardiovascular system,” in Cell and Tissue Biology: A Textbook of Histology, L. Weiss, Ed., pp. 355–400, Urban & Schwarzenberg, Baltimore, Md, USA, 6th edition, 1988. View at: Google Scholar
  4. A. Martinez-Hernandez and J. Martinez, “The role of capillarization in hepatic failure: studies in carbon tetrachloride-induced cirrhosis,” Hepatology, vol. 14, no. 5, pp. 864–874, 1991. View at: Publisher Site | Google Scholar
  5. B. Smedsrod, P. J. de Bleser, F. Braet et al., “Cell biology of liver endothelial and Kupffer cells,” Gut, vol. 35, no. 11, pp. 1509–1516, 1994. View at: Publisher Site | Google Scholar
  6. D. G. le Couteur, A. Warren, V. C. Cogger et al., “Old age and the hepatic sinusoid,” Anatomical Record, vol. 291, no. 6, pp. 672–683, 2008. View at: Publisher Site | Google Scholar
  7. F. Schaffner and H. Popper, “Capillarization of hepatic sinusoids in man,” Gastroenterology, vol. 44, pp. 239–242, 1963. View at: Google Scholar
  8. T. Horn, P. Christofferson, and J. H. Henriksen, “Alcoholic liver injury: defenestration in noncirrhotic livers—a scanning electron microscopic study,” Hepatology, vol. 7, no. 1, pp. 77–82, 1987. View at: Publisher Site | Google Scholar
  9. S. Urashima, M. Tsutsumi, K. Nakase, J.-S. Wang, and A. Takada, “Studies on capillarization of the hepatic sinusoids in alcoholic liver disease,” Alcohol and Alcoholism, vol. 28, pp. 77–84, 1993. View at: Google Scholar
  10. B. Xu, U. Broome, M. Uzunel et al., “Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis,” The American Journal of Pathology, vol. 163, no. 4, pp. 1275–1289, 2003. View at: Publisher Site | Google Scholar
  11. E. Bhunchet and K. Fujieda, “Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: a mechanism to maintain liver blood flow,” Hepatology, vol. 18, no. 6, pp. 1450–1458, 1993. View at: Publisher Site | Google Scholar
  12. L. Dubuisson, L. Boussarie, C.-A. Bedin, C. Balabaud, and P. Bioulac-Sage, “Transformation of sinusoids into capillaries in a rat model of selenium-induced nodular regenerative hyperplasia: an immunolight and immunoelectron microscopic study,” Hepatology, vol. 21, no. 3, pp. 805–814, 1995. View at: Google Scholar
  13. P. F. Lalor, W. K. Lai, S. M. Curbishley, S. Shetty, and D. H. Adams, “Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo,” World Journal of Gastroenterology, vol. 12, no. 34, pp. 5429–5439, 2006. View at: Google Scholar
  14. E. R. Weibel and G. E. Palade, “New cytoplasmic components in arterial endothelia,” Journal of Cell Biology, vol. 23, pp. 101–112, 1964. View at: Publisher Site | Google Scholar
  15. M. J. Holestelle, H. G. M. Geertzen, I. H. Straatsburg, T. M. van Gulik, and J. A. van Mourik, “Factor VIII expression in liver disease,” Thrombosis and Haemostasis, vol. 91, no. 2, pp. 267–275, 2004. View at: Google Scholar
  16. Y. Fukuda, H. Nagura, M. Imoto, and Y. Koyama, “Immunohistochemical studies on structural changes of the hepatic lobules in chronic liver diseases,” American Journal of Gastroenterology, vol. 81, no. 12, pp. 1149–1155, 1986. View at: Google Scholar
  17. C. Babbs, N. Y. Haboubi, J. M. Mellor, A. Smith, B. P. Rowan, and T. W. Warnes, “Endothelial cell transformation in primary biliary cirrhosis: a morphological and biochemical study,” Hepatology, vol. 11, no. 5, pp. 723–729, 1990. View at: Publisher Site | Google Scholar
  18. L. Gan, S. Chitturi, and G. C. Farrell, “Mechanisms and implications of age-related changes in the liver: nonalcoholic fatty liver disease in the elderly,” Current Gerontology and Geriatrics Research, vol. 2011, Article ID 831536, 12 pages, 2011. View at: Publisher Site | Google Scholar
  19. M. Noureddin, K. P. Yates, I. A. Vaughn et al., “Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients,” Hepatology, vol. 58, pp. 1644–1654, 2013. View at: Google Scholar
  20. X. Xu, L. K. Hueckstaedt, and J. Ren, “Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy,” Journal of Hepatology, vol. 59, no. 2, pp. 308–317, 2013. View at: Publisher Site | Google Scholar
  21. K. M. Mak, A. J. Kwong, E. Chu, and N. M. Hoo, “Hepatic steatosis, fibrosis, and cancer in elderly cadavers,” Anatomical Record, vol. 295, no. 1, pp. 40–50, 2012. View at: Publisher Site | Google Scholar
  22. K. M. Mak, E. Chu, K. H. V. Lau, and A. J. Kwong, “Liver fibrosis in elderly cadavers: Localization of collagen types I, III and IV, α-smooth muscle actin, and elastic fibers,” Anatomical Record, vol. 295, no. 7, pp. 1159–1167, 2012. View at: Publisher Site | Google Scholar
  23. K. M. Mak, L. L. Chen, and T. F. Lee, “Codistribution of collagen type IV and laminin in liver fibrosis of elderly cadavers: immunohistochemical marker of perisinusoidal basement membrane formation,” Anatomical Record, vol. 296, no. 6, pp. 953–964, 2013. View at: Publisher Site | Google Scholar
  24. R. Lenzi, G. Alpini, M. H. Liu, J. H. Rand, and N. Tavoloni, “Von Willebrand factor antigen is not an accurate marker of rat and guinea pig liver endothelial cells,” Liver, vol. 10, no. 6, pp. 372–379, 1990. View at: Google Scholar
  25. A. J. McLean, V. C. Cogger, G. C. Chong et al., “Age-related pseudocapillarization of the human liver,” Journal of Pathology, vol. 200, no. 1, pp. 112–117, 2003. View at: Publisher Site | Google Scholar
  26. V. C. Cogger, A. Warren, R. Fraser, M. Ngu, A. J. McLean, and D. G. Le Couteur, “Hepatic sinusoidal pseudocapillarization with aging in the non-human primate,” Experimental Gerontology, vol. 38, no. 10, pp. 1101–1107, 2003. View at: Publisher Site | Google Scholar
  27. S. N. Hilmer, V. C. Cogger, R. Fraser, A. J. McLean, D. Sullivan, and D. G. le Couteur, “Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat,” Hepatology, vol. 42, no. 6, pp. 1349–1354, 2005. View at: Publisher Site | Google Scholar

Copyright © 2014 Ki M. Mak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

660 Views | 359 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.